BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23223646)

  • 1. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
    Wong KH; Mang OW; Au KH; Law SC
    Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997-2006.
    Cheung FY; Mang OW; Law SC
    Hong Kong Med J; 2011 Apr; 17(2):89-95. PubMed ID: 21471587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trends of female lung cancer in Hong Kong: Age, period and birth cohort analysis.
    Chiu YL; Yu IT; Wong TW
    Int J Cancer; 2004 Sep; 111(3):424-30. PubMed ID: 15221972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?
    Chan JK; Loizzi V; Lin YG; Osann K; Brewster WR; DiSaia PJ
    Obstet Gynecol; 2003 Jul; 102(1):156-61. PubMed ID: 12850623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
    Hannibal CG; Cortes R; Engholm G; Kjaer SK
    Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors of epithelial ovarian cancer in young women].
    Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
    Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
    Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and projections of ovarian cancer incidence in Hong Kong: A population-based study.
    Chen X; Du J; Wang X; Wu X
    Acta Obstet Gynecol Scand; 2023 Jul; 102(7):942-949. PubMed ID: 37194221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
    Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
    Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality.
    Lee AW; Foo W; Mang O; Sze WM; Chappell R; Lau WH; Ko WM
    Int J Cancer; 2003 Feb; 103(5):680-5. PubMed ID: 12494479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male breast cancer: a population-based comparison with female breast cancer in Hong Kong, Southern China: 1997-2006.
    Kwong A; Chau WW; Mang OW; Wong CH; Suen DT; Leung R; Wong K; Lee A; Shea C; Morse E; ; Law SC
    Ann Surg Oncol; 2014 Apr; 21(4):1246-53. PubMed ID: 24337541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cavity cancer trends over the past 25 years in Hong Kong: a multidirectional statistical analysis.
    Ushida K; McGrath CP; Lo EC; Zwahlen RA
    BMC Oral Health; 2015 Jul; 15():83. PubMed ID: 26205649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.
    Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ
    Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
    O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
    J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends of esophageal cancer in Hong Kong: age, period and birth cohort analyses.
    Tse LA; Yu IT; Mang OW
    Int J Cancer; 2007 Feb; 120(4):853-8. PubMed ID: 17131316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma in Hong Kong between 1983 and 2002: a decreasing trend in incidence observed in a complex socio-political and economic setting.
    Makredes M; Hui SK; Kimball AB
    Melanoma Res; 2010 Oct; 20(5):427-30. PubMed ID: 20729764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
    Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
    Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.